微创手术器械市场按产品类型、技术、可用性、手术类型、最终用户和销售管道划分—2025-2030 年全球预测

2024 年微创手术器材市场价值为 331.9 亿美元，预计 2025 年将成长至 364.3 亿美元，复合年增长率为 10.10%，预计到 2030 年将达到 591.5 亿美元。

主要市场统计数据
基准年2024年	331.9亿美元
预计2025年	364.3亿美元
预测年份 2030	591.5亿美元
复合年增长率（%）	10.10%

了解先进的微创手术器械在改变全球病患治疗结果和手术效率方面发挥的重要作用

外科技术的进步显着改变了医护人员透过微创技术进行患者照护的方式。旨在减少创伤、进入内部解剖结构的高精度器械日益成为现代手术室的基石。外科医生越来越青睐整合了精密人体工学和先进视觉化功能的器械，这推动了这些器械在各个专业的应用。因此，器械开发人员正专注于模组化设计，以便与内视镜摄影机、充气系统和基于能量的器械无缝集成，从而优化手术安全性和疗效。

检验推动全球微创手术器械模式转移的关键技术和程序创新

微创手术正在经历一场前所未有的变革时期，其特征是创新技术与不断发展的手术模式的融合。机器人辅助平台正在重新定义精准度，使外科医生能够利用铰接式器械尖端执行复杂手术，并透过3D视觉化技术提升手术灵活性。同时，高清成像系统与萤光和扩增实境(AR) 迭加技术的集成，实现了即时组织分化，改善了术中决策，并减少了对人工评估的依赖。

全面评估2025年美国关税变化对手术器械市场供应链、成本结构和生产策略的影响

2025年，美国关税变动的累积效应将对微创器材供应链产生重大波动。对先进合金、电子控制模组和精密光学元件等进口零件征收更高的关税，迫使製造商重新评估其采购模式。虽然在美国拥有成熟业务的供应商正在获得支持，但依赖进口的製造商正面临净利率压力，而这种压力可能会以器械价格上涨的形式转嫁给下游企业。

透过对产品、技术、可用性、临床和分销细分动态的综合理解来释放策略机会

在深入了解产品细分市场后，我们发现辅助器具（包括电外科器械和扩张系统）是许多微创手术的基础工具。扩张器械（例如充气装置和球囊）能够精确控製手术空间，而可视化设备则可提供诊断和治疗性介入所需的高保真影像。引导器材（分为导管和导管导引线）有助于进入所需的解剖部位。手持器械包括扩张器、解剖器、钳子、抓钳、牵开器、剪刀和套管针，每种器械的设计都旨在满足不同的手术需求。

不断发展的医疗基础设施、报销框架和区域创新倡议揭示了区域市场的差异

近年来，微创手术器材的地区表现差异显着，反映了医疗基础设施、监管环境和报销模式的差异。在美洲，强大的医院网路和对最尖端科技的积极采用正在推动对机器人平台和精密辅助器具的需求，而采购改革则强调成本效益和基于价值的采购。

重点介绍微创手术器材领域主要参与企业的策略性措施与差异化竞争策略

微创手术器械领域的主要企业正透过多种方式实现差异化竞争，包括建立策略联盟、丰富产品系列以及大力投资研发。成熟的器械製造商正在强化其核心电外科和能量外科平台，同时拓展至先进的可视化和机器人介面，以提供全面的解决方案。

采用供应链自适应数位化整合策略与合作模式，巩固市场地位，维持成长

产业领导者应先建立供应商和建立区域製造伙伴关係关係来缓解关税带来的成本压力。采用近岸和国内生产模式可以帮助企业保持价格稳定，同时缩短前置作业时间并降低物流复杂性。

利用强大的混合方法框架，结合二手资料和专家一手资料研究，确保获得高保真的市场洞察

我们的调查方法严格结合了二手资料分析和一手定性分析，以确保研究结果可靠且可操作。首先，我们对同行评审期刊、监管备案文件和医疗保健资料库进行了全面的文献综述，以深入了解影响微创器材领域的临床实践、器材分类和政策发展。

整合市场动态、技术进步与政策挑战，规划微创手术市场的策略进步

随着微创手术器械的不断发展，相关人员必须应对快速的技术进步、动态的政策干预和不断变化的临床重点。机器人平台、先进影像处理和数位化支援工具的整合提高了手术的准确性和患者治疗效果，而关税变化导致的供应链重组凸显了製定自适应製造策略的必要性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

• 促进机器人辅助触觉回馈系统在腹腔镜手术中的整合，以提高手术精确度
• 一次性内视镜器材需求激增，以最大程度降低交叉污染风险
• 人工智慧影像识别技术的进步将指导微创手术并提供即时决策支持
• 开发柔性形状记忆合金器械以提高复杂腔内干预的可操作性
• 采用无线感测器智慧手术工具，在手术期间持续监测组织参数
• 将 MIS 设备与扩增实境视觉化平台结合，以增强手术期间的解剖定位。
• 迈向具有抗菌特性的微型奈米涂层手术器械迈进，以减少术后感染
• 适用于分散式和现场手术的可携式电池供电腹腔镜塔的新兴趋势
• 利用支援 5G 的远端微创机器人平台快速扩展远端手术能力
• 增加对使用生物分解性材料製造永续、环保的 MIS 设备的投资

第六章 市场洞察

• 波特五力分析
• PESTEL分析

第七章 2025年美国关税的累积影响

8. 微创手术器材市场（依产品类型）

• 辅助器具
• 电外科器械
• 引导装置
  • 导管
  • 导管导引线
• 手持装置
  • 扩充器
  • 削皮器
  • 镊子和抓钳
  • 抓钳
  • 牵开器
  • 剪刀
  • 套管针
• 膨胀装置
  • 气球
  • 供气设备
• 视觉化设备

第九章 微创手术器材市场：依技术

• 非机器人手术
• 机器人手术

第 10 章 微创手术器材市场（依可用性）

• 免洗设备
• 可重复使用的设备

第11章微创手术器械市场（依手术类型）

• 心胸外科
• 整形手术/减重手术
• 胃肠外科
• 妇科手术
• 整形外科
• 泌尿系统
• 血管

第 12 章微创手术器械市场（按最终用户）

• 学术研究机构
• 门诊手术中心（ASC）
• 医院
• 专科诊所

第十三章微创手术器材市场（依销售管道）

• 离线
• 在线的

14.美国微创手术器材市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 阿根廷

15. 欧洲、中东和非洲微创手术器材市场

• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 阿拉伯聯合大公国
• 沙乌地阿拉伯
• 南非
• 丹麦
• 荷兰
• 卡达
• 芬兰
• 瑞典
• 奈及利亚
• 埃及
• 土耳其
• 以色列
• 挪威
• 波兰
• 瑞士

第 16 章：亚太微创手术器械市场

• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 印尼
• 泰国
• 菲律宾
• 马来西亚
• 新加坡
• 越南
• 台湾

第十七章竞争格局

• 2024年市场占有率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Abbott Laboratories
  • Applied Medical Resources Corporation
  • Arthrex, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group Incorporated
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hologic, Inc.
  • HOYA Corporation
  • Intuitive Surgical Inc.
  • Johnson & Johnson Services, Inc.
  • Karl Storz GmbH & Co. KG
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated
  • Zimmer Biomet Holdings, Inc.
  • Clarus Medical LLC
  • Wexler Surgical, Inc.

第十八章 研究人工智慧

第十九章 研究统计

第二十章 研究联络人

第21章 研究报导

第22章 附录

The Minimally Invasive Surgical Instruments Market was valued at USD 33.19 billion in 2024 and is projected to grow to USD 36.43 billion in 2025, with a CAGR of 10.10%, reaching USD 59.15 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024]	USD 33.19 billion
Estimated Year [2025]	USD 36.43 billion
Forecast Year [2030]	USD 59.15 billion
CAGR (%)	10.10%

Discover the Critical Role of Advanced Minimally Invasive Surgical Instruments in Transforming Patient Outcomes and Surgical Efficiencies Worldwide

Advancements in surgical technology have propelled a profound shift in how medical professionals approach patient care through minimally invasive techniques. High-precision instruments designed to access internal anatomies with reduced trauma have gradually become a cornerstone in modern operating theaters. Surgeons increasingly favor devices that integrate refined ergonomics with advanced visualization capabilities, driving the ongoing adoption across a diverse range of specialties. As a result, instrument developers have focused on modular designs that allow seamless integration with endoscopic cameras, insufflation systems, and energy-based modalities to optimize procedural safety and outcomes.

Moreover, growing emphasis on patient recovery and hospital cost containment has accelerated the transition from traditional open surgeries to minimally invasive approaches. Shorter hospital stays and reduced postoperative complications contribute to improved throughput in ambulatory settings while catering to patient preferences for less invasive interventions. In response, stakeholders including device innovators, surgical teams, and healthcare administrators are collaborating to establish protocols that standardize tool usage and training, further reinforcing the clinical value proposition of minimally invasive instruments.

This executive summary synthesizes comprehensive insights into the current industry environment, highlighting transformative trends, policy influences such as tariffs, and critical segmentation dimensions spanning product categories, technology choices, and end-user adoption. By unpacking regional dynamics, competitive positioning, and actionable recommendations, this report equips decision-makers with the strategic context required to navigate a rapidly evolving market landscape.

In the sections that follow, readers will gain an in-depth exploration of technological evolutions reshaping the surgical instrument ecosystem, an assessment of policy shifts affecting cost structures and supply chains, and detailed segmentation insights that elucidate where opportunities are most compelling. Further analysis examines regional performance trends and profiles of leading participants to inform strategic decision-making in an increasingly competitive environment.

Examining the Key Technological and Procedural Innovations Driving a Paradigm Shift in Minimally Invasive Surgical Instrumentation Practices Globally

The minimally invasive surgical landscape is undergoing a period of unprecedented transformation defined by the convergence of innovative technologies and evolving procedural paradigms. Robotic-assisted platforms are redefining precision, offering surgeons the ability to execute complex maneuvers with enhanced dexterity through articulated instrument tips and three-dimensional visualization. Concurrently, integration of high-definition imaging systems with fluorescence and augmented reality overlays is enabling real-time tissue differentiation, improving intraoperative decision-making and reducing reliance on manual estimation.

Beyond hardware, artificial intelligence algorithms are being leveraged to analyze procedural video streams, optimize instrument trajectories, and predict potential complications. These digital enhancements are complemented by advancements in energy-based modalities that combine ultrasonic and bipolar capabilities within a single handheld device, streamlining procedural workflows and minimizing the number of instrument exchanges.

Regulatory and reimbursement frameworks are adapting to support these innovations, with value-based care models incentivizing outcomes over volumes and encouraging adoption of technologies that demonstrate clear patient benefit. Furthermore, virtual reality simulation platforms and haptic training modules are enhancing surgeon proficiency and reducing the learning curve associated with complex interventions, fostering widespread acceptance of minimally invasive approaches.

Together, these shifts are not only elevating procedural safety and efficacy but also reshaping stakeholder expectations across clinical, operational, and financial domains, setting the stage for sustained growth and continuous innovation in surgical instrumentation.

Evaluating the Comprehensive Effects of 2025 United States Tariff Revisions on Supply Chains Cost Structures and Production Strategies in Surgical Instrument Markets

In 2025, the cumulative effect of revised United States tariffs is creating significant ripples across the minimally invasive instrument supply chain. Heightened duties on imported components such as advanced alloys, electronic control modules, and precision optics have prompted manufacturers to reevaluate sourcing models. Suppliers with established U.S. operations are gaining traction, while import-reliant producers face margin pressures that may be passed downstream in the form of elevated instrument prices.

These measures have accelerated efforts to localize production, with original equipment manufacturers investing in domestic facilities capable of precision machining and assembly. As production footprints shift, partnerships with local suppliers of polymers, medical-grade steels, and semiconductor components are becoming more strategic, fostering a resilient ecosystem less vulnerable to international trade disruptions.

Simultaneously, cost increases have encouraged procurement teams within hospitals and ambulatory centers to pursue longer-term contracting agreements and collaborative purchasing consortia to mitigate unit price volatility. Some market participants are exploring nearshoring options in Mexico and the Caribbean to retain tariff advantages while optimizing logistics and lead times.

Looking ahead, potential renegotiations and exemptions for certain medical-device classifications could alleviate some financial burdens, yet the current environment underscores the criticality of adaptive supply chain strategies. Leaders who proactively address tariff impacts through diversified sourcing and operational agility will be best positioned to maintain competitive pricing and ensure uninterrupted delivery of essential surgical instruments.

Unleashing Strategic Opportunities Through an Integrated Understanding of Product, Technology, Usability, Clinical and Distribution Segmentation Dynamics

A nuanced understanding of product segmentation reveals that auxiliary instruments, including electrosurgical devices and inflation systems, serve as foundational tools supporting a vast array of minimally invasive procedures. Inflation devices such as insufflators and balloons enable precise control of operative spaces, while visualizing instruments deliver high-fidelity imagery crucial for diagnostic and therapeutic interventions. Guiding devices break down further into catheters and guidewires, facilitating access to targeted anatomies, and handheld instruments encompass dilators, dissectors, forceps, graspers, retractors, scissors, and trocars, each designed to fulfill distinct procedural requirements.

From a technological perspective, the dichotomy between traditional non-robotic surgery and advanced robotic-assisted platforms highlights a pivotal trend: institutions with higher procedural volumes and complex case mixes are increasingly investing in robotic systems to enhance consistency and ergonomics, whereas community hospitals and smaller centers often rely on conventional laparoscopic or endoscopic devices.

Usability considerations underscore the ongoing debate between disposable instruments that reduce cross-contamination risk and reusable options that offer lower lifecycle costs. Clinical applications span cardiothoracic, gynecological, gastrointestinal, orthopedic, urological, vascular, and cosmetic or bariatric surgeries, reflecting the breadth of minimally invasive interventions. Across these specialties, academic and research institutes drive early-stage innovation, ambulatory surgical centers prioritize efficiency, hospitals seek comprehensive instrument portfolios, and specialty clinics focus on tailored solutions.

Finally, distribution channels split between offline relationships bolstered by dedicated field representatives and online platforms that offer rapid procurement cycles. Together, these segmentation insights delineate a complex, interconnected market where targeted strategies are essential to address the diverse needs of end-users and clinical environments.

Illuminating Regional Market Variations Driven by Healthcare Infrastructure Evolution Reimbursement Frameworks and Local Innovation Initiatives

Regional performance of minimally invasive surgical instruments has diverged significantly in recent years, reflecting differing healthcare infrastructures, regulatory landscapes, and reimbursement paradigms. In the Americas, strong hospital networks and proactive adoption of cutting-edge technologies have driven demand for robotic platforms and high-precision ancillary devices, while procurement reforms emphasize cost-effectiveness and value-based procurement.

The Europe, Middle East & Africa region exhibits a multifaceted profile: Western European countries with centralized regulatory frameworks maintain rigorous device evaluation processes that encourage safety and efficacy, whereas emerging markets in the Middle East and Africa are investing in scalable minimally invasive capabilities to reduce patient referrals abroad and foster local procedural expertise. Collaborative programs between device manufacturers and regional health authorities are supporting training and infrastructure development in underserved geographies.

In Asia-Pacific, the dynamic growth of private healthcare facilities and rising surgical volumes in populous nations such as China and India have created substantial opportunities for both global leaders and local innovators. Government initiatives promoting domestic manufacturing and technology transfers are reshaping competitive dynamics, while an expanding network of ambulatory surgical centers is increasing demand for cost-efficient, single-use instruments.

This regional mosaic underscores the importance of tailored market strategies that account for local reimbursement policies, clinical practice patterns, and infrastructure maturity to fully capitalize on growth prospects.

Highlighting the Strategic Initiatives and Competitive Differentiation Tactics of Leading Participants in the Minimally Invasive Surgical Instrument Sector

Leading companies in the minimally invasive instrument arena are differentiating through a combination of strategic partnerships, product portfolio diversification, and focused investments in research and development. Established device manufacturers are enhancing core electrosurgical and energy-based platforms while expanding into advanced visualization and robotic interfaces to deliver comprehensive solutions.

Companies with strong legacy presences in reusable instruments are increasingly integrating disposable components to address heightened sterilization concerns and streamline procedural workflows. Conversely, newer entrants specializing in single-use technologies are forging alliances with academic centers to validate product efficacy and accelerate clinical adoption.

Strategic acquisitions have become a key lever for growth, enabling firms to secure proprietary materials, innovative imaging modules, and software-driven analytics capabilities. Meanwhile, collaborations with contract manufacturing organizations and technology incubators are fostering rapid prototyping and agile iteration of novel instrument designs.

As competitive pressures intensify, success hinges on the ability to anticipate shifting hospital procurement priorities, maintain strong direct and indirect distribution networks, and deliver integrated service offerings that encompass training, preventive maintenance, and software updates. Companies that align these elements effectively are best poised to capture market share and cultivate long-term customer loyalty.

Implementing Supply Chain Adaptations Digital Integration Strategies and Collaborative Models to Strengthen Market Position and Drive Sustainable Growth

Industry leaders should first cultivate supply chain resilience by diversifying sources of critical components and establishing regional manufacturing partnerships to mitigate tariff-induced cost pressures. By adopting nearshore and in-country production models, organizations can maintain pricing stability while reducing lead times and logistical complexities.

Next, investment in digital integration-such as cloud-based instrument tracking, predictive maintenance analytics, and augmented reality training modules-will strengthen clinical engagement and enhance value propositions. These technologies not only improve device utilization rates but also create recurring revenue streams through software licensing and data-driven service contracts.

Third, companies should refine portfolio strategies to balance reusable systems with single-use alternatives, aligning product offerings with evolving hospital sterilization protocols and sustainability goals. Tailored commercial models that bundle instrumentation with training, financing options, and outcome-based warranties can differentiate propositions and secure long-term contracts.

Finally, expanding collaborations with clinical centers of excellence and regulatory bodies will accelerate the validation of next-generation devices and streamline market access pathways. By engaging early in the product development cycle and harnessing real-world clinical evidence, industry leaders can anticipate clinician needs and shape favorable reimbursement frameworks, ensuring sustained adoption and rapid scale.

Leveraging a Robust Mixed-Methods Framework of Secondary Research and Primary Expert Engagement to Ensure High-Fidelity Market Insights

This research employed a rigorous methodology that combined secondary data analysis with primary qualitative insights to ensure robust and actionable findings. Initially, comprehensive literature reviews of peer-reviewed journals, regulatory filings, and healthcare databases provided a foundational understanding of clinical practices, device classifications, and policy developments influencing the minimally invasive instrument sector.

Subsequently, in-depth interviews were conducted with surgical specialists, procurement executives, and device engineers across diverse geographies to capture firsthand perspectives on technology adoption drivers, procedural challenges, and unmet clinical needs. Triangulating these primary inputs with public financial disclosures and product registries enabled identification of strategic priorities and innovation trajectories among leading organizations.

Quantitative data points were further validated through cross-referencing manufacturer catalogues, trade publications, and hospital procurement records, refining the accuracy of segmentation and competitive landscape analyses. Insights were periodically reviewed with external domain experts to confirm interpretive rigor and to adjust for emerging trends such as tariff impacts and regional policy shifts.

This blended approach, integrating qualitative depth and quantitative breadth, underpins the credibility of the conclusions and recommendations presented throughout the report, offering decision-makers confidence in the strategic roadmap defined herein.

Synthesizing Market Dynamics Technological Progress and Policy Imperatives to Chart a Strategic Path Forward in Minimally Invasive Surgery Markets

As minimally invasive surgical instruments continue to evolve, stakeholders must navigate a landscape defined by rapid technological progress, dynamic policy interventions, and shifting clinical priorities. The integration of robotic platforms, advanced imaging, and digital support tools is elevating procedural precision and patient outcomes, while supply chain reshaping driven by tariff revisions underscores the need for adaptive manufacturing strategies.

Comprehensive segmentation insights reveal that targeted product design, technology selection, and distribution channel optimization are critical to meeting diverse end-user requirements across specialties, from cardiovascular to cosmetic surgery. Regional nuances in infrastructure maturity and regulatory frameworks further emphasize the necessity of localized go-to-market approaches.

Competitive dynamics are being redefined through strategic partnerships, acquisitions, and service-oriented offerings, with leading participants forging collaborative networks to accelerate innovation and secure market share. By prioritizing actionable recommendations-such as supply chain diversification, digital integration, and evidence-based device validation-organizations can position themselves at the forefront of this high-growth sector.

Ultimately, success in the minimally invasive instrument market will depend on the agility to anticipate emergent clinical needs, the foresight to align with evolving policy landscapes, and the commitment to delivering holistic solutions that empower surgical teams and enhance patient care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Increasing integration of robotic-assisted haptic feedback systems in laparoscopic surgeries to improve precision
• 5.2. Surge in demand for single-use disposable endoscopic instruments to minimize cross-contamination risk
• 5.3. Advancements in AI-powered image recognition guiding minimally invasive procedures for real-time decision support
• 5.4. Development of flexible shape-memory alloy instruments for enhanced maneuverability in complex endoluminal interventions
• 5.5. Adoption of wireless sensor-enabled smart surgical tools for continuous intraoperative monitoring of tissue parameters
• 5.6. Integration of augmented reality visualization platforms with MIS instruments for enhanced anatomical orientation during surgery
• 5.7. Shift towards miniaturized nanocoated surgical instruments offering antimicrobial properties to reduce postoperative infections
• 5.8. Emerging trend of portable battery-operated laparoscopic towers for decentralized and field-based surgical procedures
• 5.9. Rapid expansion of tele-surgery capabilities using 5G-enabled remote-controlled minimally invasive robotic platforms
• 5.10. Growing investment in sustainable eco-friendly manufacturing of MIS instruments incorporating biodegradable materials

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Minimally Invasive Surgical Instruments Market, by Product Type

• 8.1. Introduction
• 8.2. Auxiliary Instruments
• 8.3. Electrosurgical Instruments
• 8.4. Guiding Devices
  • 8.4.1. Catheters
  • 8.4.2. Guidewires
• 8.5. Handheld Instruments
  • 8.5.1. Dilators
  • 8.5.2. Dissectors
  • 8.5.3. Forceps & Graspers
  • 8.5.4. Graspers
  • 8.5.5. Retractors
  • 8.5.6. Scissors
  • 8.5.7. Trocars
• 8.6. Inflation Devices
  • 8.6.1. Balloons
  • 8.6.2. Insufflators
• 8.7. Visualizing Instruments

9. Minimally Invasive Surgical Instruments Market, by Technology

• 9.1. Introduction
• 9.2. Non-Robotic Surgery
• 9.3. Robotic Surgery

10. Minimally Invasive Surgical Instruments Market, by Usability

• 10.1. Introduction
• 10.2. Disposable Instruments
• 10.3. Reusable Instruments

11. Minimally Invasive Surgical Instruments Market, by Surgery Type

• 11.1. Introduction
• 11.2. Cardiothoracic Surgery
• 11.3. Cosmetic/Bariatric Surgery
• 11.4. Gastrointestinal Surgery
• 11.5. Gynecological Surgery
• 11.6. Orthopedic Surgery
• 11.7. Urological Surgery
• 11.8. Vascular

12. Minimally Invasive Surgical Instruments Market, by End-User

• 12.1. Introduction
• 12.2. Academic & Research Institutes
• 12.3. Ambulatory Surgical Centers (ASCs)
• 12.4. Hospitals
• 12.5. Specialty Clinics

13. Minimally Invasive Surgical Instruments Market, by Sales Channel

• 13.1. Introduction
• 13.2. Offline
• 13.3. Online

14. Americas Minimally Invasive Surgical Instruments Market

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. Argentina

15. Europe, Middle East & Africa Minimally Invasive Surgical Instruments Market

• 15.1. Introduction
• 15.2. United Kingdom
• 15.3. Germany
• 15.4. France
• 15.5. Russia
• 15.6. Italy
• 15.7. Spain
• 15.8. United Arab Emirates
• 15.9. Saudi Arabia
• 15.10. South Africa
• 15.11. Denmark
• 15.12. Netherlands
• 15.13. Qatar
• 15.14. Finland
• 15.15. Sweden
• 15.16. Nigeria
• 15.17. Egypt
• 15.18. Turkey
• 15.19. Israel
• 15.20. Norway
• 15.21. Poland
• 15.22. Switzerland

16. Asia-Pacific Minimally Invasive Surgical Instruments Market

• 16.1. Introduction
• 16.2. China
• 16.3. India
• 16.4. Japan
• 16.5. Australia
• 16.6. South Korea
• 16.7. Indonesia
• 16.8. Thailand
• 16.9. Philippines
• 16.10. Malaysia
• 16.11. Singapore
• 16.12. Vietnam
• 16.13. Taiwan

17. Competitive Landscape

• 17.1. Market Share Analysis, 2024
• 17.2. FPNV Positioning Matrix, 2024
• 17.3. Competitive Analysis
  • 17.3.1. Abbott Laboratories
  • 17.3.2. Applied Medical Resources Corporation
  • 17.3.3. Arthrex, Inc.
  • 17.3.4. B. Braun SE
  • 17.3.5. Boston Scientific Corporation
  • 17.3.6. CONMED Corporation
  • 17.3.7. Cook Group Incorporated
  • 17.3.8. Fujifilm Holdings Corporation
  • 17.3.9. GE Healthcare
  • 17.3.10. Hologic, Inc.
  • 17.3.11. HOYA Corporation
  • 17.3.12. Intuitive Surgical Inc.
  • 17.3.13. Johnson & Johnson Services, Inc.
  • 17.3.14. Karl Storz GmbH & Co. KG
  • 17.3.15. Koninklijke Philips N.V.
  • 17.3.16. Medtronic PLC
  • 17.3.17. Olympus Corporation
  • 17.3.18. Richard Wolf GmbH
  • 17.3.19. Siemens Healthineers AG
  • 17.3.20. Smith & Nephew PLC
  • 17.3.21. Stryker Corporation
  • 17.3.22. Teleflex Incorporated
  • 17.3.23. Zimmer Biomet Holdings, Inc.
  • 17.3.24. Clarus Medical LLC
  • 17.3.25. Wexler Surgical, Inc.

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

LIST OF FIGURES

• FIGURE 1. MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET RESEARCH PROCESS
• FIGURE 2. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 3. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 4. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 6. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 8. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2024 VS 2030 (%)
• FIGURE 10. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2024 VS 2030 (%)
• FIGURE 12. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 14. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
• FIGURE 16. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 17. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 18. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 19. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 20. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 23. ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 24. ASIA-PACIFIC MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 25. MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 26. MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2024
• FIGURE 27. MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: RESEARCHAI
• FIGURE 28. MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: RESEARCHSTATISTICS
• FIGURE 29. MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: RESEARCHCONTACTS
• FIGURE 30. MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: RESEARCHARTICLES

LIST OF TABLES

• TABLE 1. MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, 2025-2030 (USD MILLION)
• TABLE 5. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 7. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 9. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 11. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY AUXILIARY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY AUXILIARY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 13. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 15. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 17. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY CATHETERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 19. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 21. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 23. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 25. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY DILATORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY DILATORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 27. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY DISSECTORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY DISSECTORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 29. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY FORCEPS & GRASPERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY FORCEPS & GRASPERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 31. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GRASPERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GRASPERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 33. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY RETRACTORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 35. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SCISSORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SCISSORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 37. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TROCARS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TROCARS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 39. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 41. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 43. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY BALLOONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY BALLOONS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 45. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INSUFFLATORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INSUFFLATORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 47. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 49. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY VISUALIZING INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY VISUALIZING INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 51. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 53. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY NON-ROBOTIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY NON-ROBOTIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 55. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY ROBOTIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY ROBOTIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 57. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 59. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 61. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY REUSABLE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY REUSABLE INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 63. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 65. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 67. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COSMETIC/BARIATRIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COSMETIC/BARIATRIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 69. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GASTROINTESTINAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GASTROINTESTINAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 71. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 73. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 75. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY UROLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY UROLOGICAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 77. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY VASCULAR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY VASCULAR, BY REGION, 2025-2030 (USD MILLION)
• TABLE 79. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 81. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 83. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2025-2030 (USD MILLION)
• TABLE 85. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 87. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 89. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
• TABLE 91. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 93. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 95. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 96. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 97. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 98. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 99. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 100. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 101. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 102. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 103. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 104. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 105. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 106. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 107. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 108. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 109. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 110. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 111. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 112. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
• TABLE 113. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. AMERICAS MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 115. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 116. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 117. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 118. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 119. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 120. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 121. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 122. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 123. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 124. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 125. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 126. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 127. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 128. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 129. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 130. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 131. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 132. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
• TABLE 133. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
• TABLE 134. UNITED STATES MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
• TABLE 135. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 136. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 137. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 138. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 139. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 140. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 141. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 142. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 143. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 144. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 145. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 146. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 147. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 148. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 149. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 150. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 151. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 152. CANADA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
• TABLE 153. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 154. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 155. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 156. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 157. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 158. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 159. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 160. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 161. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 162. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 163. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 164. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 165. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 166. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 167. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 168. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 169. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 170. MEXICO MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
• TABLE 171. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 172. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 173. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 174. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 175. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 176. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 177. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 178. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 179. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 180. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 181. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 182. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 183. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 184. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 185. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 186. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 187. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 188. BRAZIL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
• TABLE 189. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 190. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 191. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 192. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 193. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 194. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 195. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 196. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 197. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 198. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 199. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 200. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 201. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 202. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 203. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 204. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 205. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 206. ARGENTINA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 215. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 217. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 227. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 228. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 230. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 232. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 234. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 236. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 238. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 240. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 242. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 243. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 244. UNITED KINGDOM MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
• TABLE 245. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 246. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 247. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 248. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 249. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 250. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 251. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 252. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 253. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 254. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 255. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 256. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 257. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 258. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 259. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 260. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 261. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
• TABLE 262. GERMANY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
• TABLE 263. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 264. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
• TABLE 265. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2018-2024 (USD MILLION)
• TABLE 266. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY GUIDING DEVICES, 2025-2030 (USD MILLION)
• TABLE 267. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 268. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY HANDHELD INSTRUMENTS, 2025-2030 (USD MILLION)
• TABLE 269. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2018-2024 (USD MILLION)
• TABLE 270. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY INFLATION DEVICES, 2025-2030 (USD MILLION)
• TABLE 271. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 272. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 273. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2018-2024 (USD MILLION)
• TABLE 274. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY USABILITY, 2025-2030 (USD MILLION)
• TABLE 275. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
• TABLE 276. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY SURGERY TYPE, 2025-2030 (USD MILLION)
• TABLE 277. FRANCE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SIZE, BY END-USER, 2018-202